CURRENT METHODS OF ASSESSING AND TREATING CARCINOMA IN SITU OF THE BLADDER WITH OR WITHOUT INVOLVEMENT OF THE PROSTATIC URETHRA-Reference-Cited by-同舟云学术

CURRENT METHODS OF ASSESSING AND TREATING CARCINOMA IN SITU OF THE BLADDER WITH OR WITHOUT INVOLVEMENT OF THE PROSTATIC URETHRA

Published:1995-06 Issue:s2 Volume:2 Page:8-22
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J Urol

Author:

Kurth KH,Schellhammer PF,Okajima E.,Akdas A.,Jakse G.,Hen HW,Silva F Calais,Fukushima S.,Nagayama T.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.1995.tb00475.x/fullpdf

Reference124 articles.

1. Carcinoma in Situ of the Urinary Tract

2. 2. G. Friedell, T. Kotake, H. Barlebo, G. Jakse, S. Fukushima, M. Melamed, S. Cohen, G. Farrow, T. Kakizoe, W. Vahlensieck, T. Niijima, Y. Aso, W. Koontz, G. Prout, and L. Denis, Transitional cell carcinomain situ. In: ) Consensus Development in Clinical Bladder Cancer Research. Proceedings of the Second and Third International Consensus Development Symposia, 1993 ; 55 -64 .

3. Carcinoma In Situ: Comments on the Pathobiology of a Paradox

4. Urothelial Dysplasia

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

2. ABO Blood Type and Urinary Bladder Cancer: Phenotype, Genotype, Allelic Association with a Clinical or Histological Stage and Recurrence Rate;Global Medical Genetics;2024-07-22

3. The Current Role of Contrast-Enhanced Ultrasound (CEUS) in the Diagnosis and Staging of Bladder Cancer: A Review of the Available Literature;Life;2024-07-09

4. Diagnostic Applications of Nuclear Medicine: Kidney and Bladder Cancer;Nuclear Oncology;2022

5. Diagnostic Applications of Nuclear Medicine: Kidney and Bladder Cancer;Nuclear Oncology;2022